title: Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
authors.affiliation: Diabetes Center, Massachusetts General Hospital, Boston, MA 02114, USA. dnathan@partners.org
authors.forename: David M
authors.initials: DM
authors.lastname: Nathan
authors.forename: John B
authors.initials: JB
authors.lastname: Buse
authors.forename: Mayer B
authors.initials: MB
authors.lastname: Davidson
authors.forename: Ele
authors.initials: E
authors.lastname: Ferrannini
authors.forename: Rury R
authors.initials: RR
authors.lastname: Holman
authors.forename: Robert
authors.initials: R
authors.lastname: Sherwin
authors.forename: Bernard
authors.initials: B
authors.lastname: Zinman
mesh_terms: D000465:Algorithms; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000188:drug therapy; D005060:Europe; D006801:Humans; D006943:Hyperglycemia / Q000517:prevention & control*; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008019:Life Style; D012955:Societies, Medical; D045162:Thiazolidinediones / Q000627:therapeutic use*; D014481:United States
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones